Philotheek: what changed
What changed
Philotheek
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€98,117
2024 · €80,612+€17,505
Equity
€439,251
2024 · €400,133+€39,119
Cash
€12,267
2024 · €44,286-€32,019
Balance sheet total
€1.1m
2024 · €1.0m+€30,030
Largest movements
Assets
- Financial fixed assets +€45,000
up €45,000 (+4.6%), from €985,468 to €1.0m
- Cash -€32,019
down €32,019 (-72.3%), from €44,286 to €12,267
mainly Debts after one year (-€64,049) and Contributions, distributions and other (-€58,999)
- Receivables within one year +€19,080
new in 2025: €19,080
Equity and liabilities
- Debts after one year -€64,049
down €64,049 (-14.3%), from €446,939 to €382,889
- Other debts +€51,879
up €51,879 (+52.4%), from €98,983 to €150,862
- Reserves +€39,119
up €39,119 (+10.3%), from €381,533 to €420,651
Income statement
- Financial income +€19,999
up €19,999 (+50.0%), from €40,005 to €60,004
- Taxes +€1,533
up €1,533 (+6.1%), from €25,009 to €26,542
- Gross operating margin -€1,370
down €1,370 (-1.7%), from €79,253 to €77,883
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€80,612
Gross operating margin
-€1,370
Depreciation
+€198
Other operating charges
-€39
Financial income
+€19,999
Financial charges
+€251
Taxes
-€1,533
Result 2025
€98,117
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€135,216
Investment
-€45,003
Financing
-€122,232
Cash 2024
€44,286
From operations (derived)
+€135,216
Net result for the year
+€98,117
Receivables within one year
-€19,080
Deferred charges and accrued income
+€2,033
Trade debts
+€31
Tax, wage and social debts
+€1,720
Other debts
+€51,879
Accrued charges and deferred income
+€515
Investment (derived)
-€45,003
Investment in fixed assets (net)
-€45,000
Current investments
-€3
Financing
-€122,232
Debts after one year
-€64,049
Current portion of long-term debt
+€816
Contributions, distributions and other
-€58,999
Cash 2025
€12,267
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,032,519 | €1,062,549 | +€30,030 | +2.9% |
| Fixed assets | 21/28 | €985,468 | €1,030,468 | +€45,000 | +4.6% |
| Financial fixed assets | 28 | €985,468 | €1,030,468 | +€45,000 | +4.6% |
| Current assets | 29/58 | €47,050 | €32,081 | -€14,970 | -31.8% |
| Amounts receivable within one year | 40/41 | - | €19,080 | +€19,080 | |
| Other amounts receivable | 41 | - | €19,080 | +€19,080 | |
| Current investments | 50/53 | €406 | €408 | +€3 | +0.6% |
| Cash at bank and in hand | 54/58 | €44,286 | €12,267 | -€32,019 | -72.3% |
| Deferred charges and accrued income | 490/1 | €2,359 | €326 | -€2,033 | -86.2% |
| Total equity and liabilities | 10/49 | €1,032,519 | €1,062,549 | +€30,030 | +2.9% |
| Equity | 10/15 | €400,133 | €439,251 | +€39,119 | +9.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €381,533 | €420,651 | +€39,119 | +10.3% |
| Distributable reserves | 133 | €381,533 | €420,651 | +€39,119 | +10.3% |
| Amounts payable | 17/49 | €632,386 | €623,298 | -€9,088 | -1.4% |
| Amounts payable after more than one year | 17 | €446,939 | €382,889 | -€64,049 | -14.3% |
| Financial debts | 170/4 | €446,939 | €382,889 | -€64,049 | -14.3% |
| Amounts payable within one year | 42/48 | €177,024 | €231,469 | +€54,446 | +30.8% |
| Current portion of amounts payable after more than one year | 42 | €70,648 | €71,464 | +€816 | +1.2% |
| Trade debts | 44 | €968 | €998 | +€31 | +3.2% |
| Suppliers | 440/4 | €968 | €998 | +€31 | +3.2% |
| Taxes, remuneration and social security | 45 | €6,425 | €8,145 | +€1,720 | +26.8% |
| Taxes | 450/3 | €6,425 | €8,145 | +€1,720 | +26.8% |
| Other amounts payable | 47/48 | €98,983 | €150,862 | +€51,879 | +52.4% |
| Accrued charges and deferred income | 492/3 | €8,424 | €8,939 | +€515 | +6.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €198 | - | -€198 | |
| Other operating charges | 640/8 | €1,498 | €1,538 | +€39 | +2.6% |
| Gross operating margin | 9900 | €79,253 | €77,883 | -€1,370 | -1.7% |
| Operating profit (loss) | 9901 | €77,557 | €76,346 | -€1,212 | -1.6% |
| Financial income | 75/76B | €40,005 | €60,004 | +€19,999 | +50.0% |
| Recurring financial income | 75 | €40,005 | €60,004 | +€19,999 | +50.0% |
| Financial charges | 65/66B | €11,941 | €11,690 | -€251 | -2.1% |
| Recurring financial charges | 65 | €11,941 | €11,690 | -€251 | -2.1% |
| Profit (loss) for the period before taxes | 9903 | €105,621 | €124,660 | +€19,038 | +18.0% |
| Income taxes | 67/77 | €25,009 | €26,542 | +€1,533 | +6.1% |
| Profit (loss) for the period | 9904 | €80,612 | €98,117 | +€17,505 | +21.7% |
| Profit (loss) for the period to be appropriated | 9905 | €80,612 | €98,117 | +€17,505 | +21.7% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.